News Focus
News Focus
icon url

Biowatch

11/11/21 5:58 PM

#240317 RE: DewDiligence #240315

Its use for cancer seems to be diametrically opposite to its use to reduce inflammation from arthritis and other ailments resulting from autoimmune reactions.

It depends entirely on what part of the immune system you want to activate, or suppress, and as it is a complex system, people may not know all the answers.
icon url

dewophile

11/11/21 8:54 PM

#240323 RE: DewDiligence #240315

This is an antagonist that is preclinical. The lead is an agonist that is in phase 1.